Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N E Kay

Showing results (131-140 of 149) with videos related to

Pageof 15
Sort By:
Blood|June 22, 2001
Blood levels of immune cells predict survival in myeloma patients: results of an Eastern Cooperative Oncology Group phase 3 trial for newly diagnosed multiple myeloma patientsN E Kay, T L Leong, N Bone, et al.
American Journal of Hematology|August 10, 1999
Prognostic significance of the S-phase fraction of light-chain-restricted cytoplasmic immunoglobulin (cIg) positive plasma cells in patients with newly diagnosed multiple myeloma enrolled on Eastern Cooperative Oncology Group treatment trial E9486M C Trendle, T Leong, R A Kyle, et al.
Leukemia|November 13, 2013
The tumor suppressor axis p53/miR-34a regulates Axl expression in B-cell chronic lymphocytic leukemia: implications for therapy in p53-defective CLL patientsJ Boysen, S Sinha, T Price-Troska, et al.
Leukemia|May 3, 2002
B-CLL cells are capable of synthesis and secretion of both pro- and anti-angiogenic moleculesN E Kay, N D Bone, R C Tschumper, et al.
Cytogenetic and Genome Research|April 4, 2013
Experimental designs for array comparative genomic hybridization technologyS K McDonnell, S M Riska, E W Klee, et al.
Leukemia|August 3, 2016
Dynamics of microvesicle generation in B-cell chronic lymphocytic leukemia: implication in disease progressionJ Boysen, M Nelson, G Magzoub, et al.
Leukemia|August 28, 2015
Risk of non-hematologic cancer in individuals with high-count monoclonal B-cell lymphocytosisB M Solomon, K G Chaffee, J Moreira, et al.
Blood|April 18, 1998
Plasmablastic morphology--an independent prognostic factor with clinical and laboratory correlates: Eastern Cooperative Oncology Group (ECOG) myeloma trial E9486 report by the ECOG Myeloma Laboratory GroupP R Greipp, T Leong, J M Bennett, et al.
Leukemia|June 22, 2001
Deletions of chromosome 13 in multiple myeloma identified by interphase FISH usually denote large deletions of the q arm or monosomyR Fonseca, M M Oken, D Harrington, et al.
British Journal of Haematology|February 15, 2002
Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemiaD F Jelinek, R C Tschumper, S M Geyer, et al.
Pageof 15

Showing results (131-140 of 149) with videos related to

Sort By:
Pageof 15
Blood|June 22, 2001
Blood levels of immune cells predict survival in myeloma patients: results of an Eastern Cooperative Oncology Group phase 3 trial for newly diagnosed multiple myeloma patientsN E Kay, T L Leong, N Bone, et al.
American Journal of Hematology|August 10, 1999
Prognostic significance of the S-phase fraction of light-chain-restricted cytoplasmic immunoglobulin (cIg) positive plasma cells in patients with newly diagnosed multiple myeloma enrolled on Eastern Cooperative Oncology Group treatment trial E9486M C Trendle, T Leong, R A Kyle, et al.
Leukemia|November 13, 2013
The tumor suppressor axis p53/miR-34a regulates Axl expression in B-cell chronic lymphocytic leukemia: implications for therapy in p53-defective CLL patientsJ Boysen, S Sinha, T Price-Troska, et al.
Leukemia|May 3, 2002
B-CLL cells are capable of synthesis and secretion of both pro- and anti-angiogenic moleculesN E Kay, N D Bone, R C Tschumper, et al.
Cytogenetic and Genome Research|April 4, 2013
Experimental designs for array comparative genomic hybridization technologyS K McDonnell, S M Riska, E W Klee, et al.
Leukemia|August 3, 2016
Dynamics of microvesicle generation in B-cell chronic lymphocytic leukemia: implication in disease progressionJ Boysen, M Nelson, G Magzoub, et al.
Leukemia|August 28, 2015
Risk of non-hematologic cancer in individuals with high-count monoclonal B-cell lymphocytosisB M Solomon, K G Chaffee, J Moreira, et al.
Blood|April 18, 1998
Plasmablastic morphology--an independent prognostic factor with clinical and laboratory correlates: Eastern Cooperative Oncology Group (ECOG) myeloma trial E9486 report by the ECOG Myeloma Laboratory GroupP R Greipp, T Leong, J M Bennett, et al.
Leukemia|June 22, 2001
Deletions of chromosome 13 in multiple myeloma identified by interphase FISH usually denote large deletions of the q arm or monosomyR Fonseca, M M Oken, D Harrington, et al.
British Journal of Haematology|February 15, 2002
Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemiaD F Jelinek, R C Tschumper, S M Geyer, et al.
Pageof 15